EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Diminishing reactogenicity with preserved immunogenicity in COVID-19 vaccines: A longitudinal observation from primary to updated booster vaccine cohorts

Hyun Myung Kang, Ho Jun Lee, Jin Yang Baek, Hye-Jin Kim, Young Jae Lee, Ju-Yeon Choi, Hye-Sook Jeong, Eui Ho Kim, Kyong Ran Peck, Jae-Hoon Ko

Journal of Infection and Public Health · 2025

DOI: 10.1016/j.jiph.2025.102794 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Infection and Public Health, 2025. Verfasst von Hyun Myung Kang und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Internal Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Republic of Korea. Hauptthemen laut MEDLINE: COVID-19 Vaccines, COVID-19, Immunization, Secondary, Immunogenicity, Vaccine. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 34 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Korea National Institute of Health.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

COVID-19 VaccinesCOVID-19Immunization, SecondaryImmunogenicity, VaccineHumansMiddle AgedLongitudinal StudiesMaleFemaleAdultAntibodies, ViralSARS-CoV-2AgedYoung AdultAntibodies, NeutralizingAdolescent

Stichwörter der Autor:innen

COVID-19ImmunogenicityLongitudinal studyReactogenicityVaccine

Substanzen

COVID-19 VaccinesAntibodies, ViralAntibodies, Neutralizing

Autor:innen und Institutionen

  • Department of Internal Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Republic of Korea.
  • Sungkyunkwan University School of Medicine, Suwon, Gyeonggi-do, Republic of Korea.
  • Asia Pacific Foundation for Infectious Diseases (APFID), Seoul, Republic of Korea; Division of Infectious Diseases, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Repu…
  • Center for Vaccine Research, National Institute of Infectious Diseases, National Institute of Health, Korea Disease Control and Prevention Agency, Cheongju, Republic of Korea.
  • Viral Immunology Laboratory, Institut Pasteur Korea, Seongnam, Republic of Korea.
  • Division of Infectious Diseases, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Republic of Korea.

Förderung

  • Korea National Institute of Health

Zitieren

APA

Kang, H. M., Lee, H. J., Baek, J. Y., Kim, H. J., Lee, Y. J., Choi, J. Y., Jeong, H. S., Kim, E. H., Peck, K. R., & Ko, J. H. (2025). Diminishing reactogenicity with preserved immunogenicity in COVID-19 vaccines: A longitudinal observation from primary to updated booster vaccine cohorts. Journal of Infection and Public Health. https://doi.org/10.1016/j.jiph.2025.102794

Vancouver

Kang HM, Lee HJ, Baek JY, Kim HJ, Lee YJ, Choi JY, et al. Diminishing reactogenicity with preserved immunogenicity in COVID-19 vaccines: A longitudinal observation from primary to updated booster vaccine cohorts. Journal of Infection and Public Health. 2025. doi:10.1016/j.jiph.2025.102794

BibTeX
@article{Kang2025,
  author = {Kang, Hyun Myung and Lee, Ho Jun and Baek, Jin Yang and Kim, Hye-Jin and Lee, Young Jae and Choi, Ju-Yeon and Jeong, Hye-Sook and Kim, Eui Ho and Peck, Kyong Ran and Ko, Jae-Hoon},
  title = {Diminishing reactogenicity with preserved immunogenicity in COVID-19 vaccines: A longitudinal observation from primary to updated booster vaccine cohorts},
  journal = {Journal of Infection and Public Health},
  year = {2025},
  doi = {10.1016/j.jiph.2025.102794}
}
Kostenlos starten →